# Boom Capital Ventures

> Boom Capital Ventures is a VC fund in San Francisco backing Biotechnology and Health Care. See 27 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: San Francisco, United States
- Total investments: 27
- Last investment: Mar 2025
- Lead investor: 7%
- Last fund: Mar 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/boomcapital
- Website: https://www.boomcap.co

Boom Capital Ventures is a VC fund in San Francisco focused on Biotechnology and Health Care. Boom Capital is a pre-seed fund for deeply technical, under-networked founders trying to build their companies. It was incorporated in 2017 and is based in San Francisco, California.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.8M–$15M |
| Series A | $17M–$52M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 13 | 48% |
| Health Care | 9 | 33% |
| Artificial Intelligence | 6 | 22% |
| Therapeutics | 4 | 15% |
| Machine Learning | 4 | 15% |

27 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 15 | 56% |
| Series A | 5 | 19% |
| Pre-Seed | 1 | 4% |
| Series B | 1 | 4% |
| Funding Round | 1 | 4% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 16 | 59% |
| Canada | 1 | 4% |
| France | 1 | 4% |
| Germany | 1 | 4% |
| Singapore | 1 | 4% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Olio Labs | Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. |  |  | Mar 19, 2025 |  |
| Olio Labs | Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. | $4.5M | Seed | Mar 19, 2025 |  |
| Bioptimus | Bioptimus is a developer of a universal AI foundation model that connects biology at all sizes, from molecules to cells, tissues, and entire organisms. The company's technology turns multiscale data into actionable representations, allowing clients to spark breakthrough discoveries and expedite biomedical innovation. | $41M | Series A | Jan 14, 2025 |  |
| Waypoint Bio | Optimizing cell therapy with spatial biology | $14.5M | Seed | Jun 28, 2024 |  |
| Nabla Bio | Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins. | $26M | Series A | May 14, 2024 |  |
| BioLoomics | BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays. | $8.7M | Seed | Sep 19, 2023 |  |
| Sonera Magnetics | Sonera Magnetics develops a technology for high-performance, non-invasive brain-computer interfaces to democratize access to the brain.Its core technology enables them to detect signals from the brain at performance levels comparable to the best diagnostic tools that rely on superconducting sensors. It can detect high-quality magnetic signalsfrom neurons firing in the brain using a non-invasive, low-cost, and low-power system - enabling a practical brain-computer interface. ‍Sonera’s portable brain imaging systems can be used to provide concordant evidence for the diagnosis and treatment of neurological disorders, such as epilepsy and dementia.The company was founded in 2018 by Nishita Deka, Dominic Labanowski, and Sayeef Salahuddin in Berkeley, California. | $11M | Seed | Sep 12, 2023 |  |
| Harmonic Discovery | Harmonic Discovery operates as a pharmaceutical company that develops a platform that combines computing and experimentation. | $8M | Seed | Sep 08, 2022 |  |
| Monod Bio | Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Its biosensor platform combines binding, transduction, and amplification to detect a range of target molecules. It utilizes recent advances in computational protein engineering to create highly modular bio-sensing nano switches that stimulate rapid,sensitive, and inexpensive analytical assays.Monod Bio was founded in 2021 and is headquartered in Seattle, Washington. | $25M | Seed | Aug 15, 2022 |  |
| Molecule | Molecule is a software platform used to decentralise intellectual property development in the biotech industry. The company was founded in 2020 by Paul Kohlhaas and Tyler Golato and is headquartered in Schaffhausen, Switzerland. | $12.7M | Seed | Jun 13, 2022 |  |

10 of 27 investments shown.

## Co-investors
- [Boom Capital](https://shizune.co/investors/profile/boom-capital) — VC Fund, 14 deals together
- [Fifty Years](https://shizune.co/investors/profile/fifty-years) — VC Fund, 5 deals together
- [True Ventures](https://shizune.co/investors/profile/true-ventures) — VC Fund, 5 deals together
- [Next Coast Ventures](https://shizune.co/investors/profile/next-coast-ventures-2) — VC Fund, 4 deals together
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 4 deals together
- [Big Idea Ventures](https://shizune.co/investors/profile/big-idea-ventures) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Blue Horizon Corporation](https://shizune.co/investors/profile/blue-horizon-corporation) — VC Fund
- [CircleUp](https://shizune.co/investors/profile/circleup-growth-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Food and Beverage VC Funds in Singapore](https://shizune.co/investors/food-and-beverage-vc-funds-singapore)
- [Organic Food Investors in Asia](https://shizune.co/investors/organic-food-investors-asia)
- [Organic Food VC Funds in Asia](https://shizune.co/investors/organic-food-vc-funds-asia)
- [Organic Food VC Funds in Singapore](https://shizune.co/investors/organic-food-vc-funds-singapore)
- [Food and Beverage Investors in Singapore](https://shizune.co/investors/food-and-beverage-investors-singapore)

## FAQ

### What does Boom Capital Ventures invest in?

Boom Capital Ventures invests primarily in Biotechnology, Health Care and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 27 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Boom Capital Ventures's check size?

Boom Capital Ventures typically joins rounds of $2.8M–$15M at Seed and $17M–$52M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Boom Capital Ventures participates in.

### When did Boom Capital Ventures last invest?

The most recent investment recorded for Boom Capital Ventures closed in Mar 2025. Shizune tracks 27 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co